Ketryx, a Boston, MA-based provider of connected application lifecycle management software for the life sciences industry, raised $14M in Series A funding. The company intends to use the funds to accelerate its product development and commercial expansion. Led by Founder and CEO Erez Kaminski, Ketryx provides connected application lifecycle management software for the life sciences industry, which enable companies building FDA-regulated software and AI-based applications to accelerate development through modern cloud-based tools while improving quality and compliance. It creates a real-time, and traceable, single solution by overlaying product development tools and connecting all items, risks, code, and tests. This enables teams to reduce their time to market with automated documentation and improve their quality and compliance through the enforcement of SOPs across connected systems.